UNSPSC 41131717: Electrophoretic hemoglobin analysis system

In this classification an electrophoretic hemoglobin analysis system is a device that electrophoretically separates and identifies normal and abnormal hemoglobin types as an aid in the diagnosis of anemia or erythrocytosis (increased total red cell mass) due to a hemoglobin abnormality US FDA regulates Electrophoretic hemoglobin analysis system under 21 CFR 864.7440 and under FDA product code OOX.

UNSPSC 41131717 Electrophoretic hemoglobin analysis system is a Commodity code that, based on recent state and local solicitations, encompasses drug and alcohol testing services, laboratory screening and confirmation testing, and related specimen collection operations rather than the analytical equipment the code name suggests. State and local governments procuring under this code are pursuing offender drug testing, pre-employment and fitness-for-duty screening, and forensic toxicology analysis. Issuing bodies span county community supervision departments, county human resources and public safety functions, municipal health agencies, county forensic laboratories, state public safety offices, and higher-education institutions. Collin County Community Supervision and Corrections Department in Texas, Seminole County and Collier County in Florida, Benton County in Oregon, Pinellas County in Florida, Clay County in Florida, the State of Oregon, the State of Nevada Department of Public Safety, and City Colleges of Chicago have all posted solicitations under or overlapping with this code in the past four months.

Recent activity concentrates in Florida and Texas, with secondary activity in Oregon, Nevada, and Illinois. Representative opportunities include Collin County's RFP 2026-327 for offender specimen collection and drug testing services (two collection sites in Plano and McKinney, approximately 25,031 tests annually, $600,000 estimated contract value, proposals due July 23, 2026), Benton County, Oregon's RFP for urinalysis testing services supporting a family treatment court program with twice-weekly testing and secure web-based result reporting (proposals due July 7, 2026), City Colleges of Chicago's RFP MWJ2603 for employment screening services covering pre-employment drug testing, fitness-for-duty services, and criminal background investigations for 1,500–1,600 candidates annually across a seven-college system (proposals due March 30, 2026, with 25% MBE and 7% WBE participation goals), and Pinellas County, Florida's procurement of certified reference materials and drug standards for forensic drug analysis through a competitive quote process (funded by the Paul Coverdell Forensic Sciences Improvement Act Program, approximately $49,034 designated for equipment and supplies). Testing specifications commonly include immunoassay screening with confirmatory testing via LC/MS/MS or GC/MS, SAMHSA or CLIA lab certification requirements, and electronic reporting.